Learn More
Medchemexpress LLC Darifenacin | 133099-04-4 | 99.8% | C28H30N2O2 | 5 MG

Supplier: Medchemexpress LLC HYA00335MG
Darifenacin is a selective and orally active M3 muscarinic receptor (M3R) antagonist. It is primarily used in the study of urinary incontinence and symptoms of overactive bladder. Additionally, it has demonstrated potential anti-tumor effects by inhibiting tumor growth in colorectal cancer cells.
- Selective M3 muscarinic receptor antagonist (pKi of 8.9).
- Binds >20-fold more specifically to M3R.
- Inhibits tumor growth in colorectal cancer cells.
- Used in studies for urinary incontinence and overactive bladder.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.